November 2021 Test Bulletin

November 5, 2021

Alverno Laboratories issued important updates for healthcare providers, including a transition of Cystic Fibrosis genetic testing to ARUP due to a vendor discontinuation, Streptococcus pneumoniae MIC breakpoints for Tetracycline aligned with FDA/CLSI standards, a C-peptide reference range update reflecting a new platform, and a protocol change for Thyroglobulin testing, now screening for antibodies and using LC-MS/MS technology. Additionally, quantitative viral load testing for Hepatitis B, Hepatitis C, and HIV will shift to Abbott Alinity m instrumentation, IgE allergen reporting will include a new "0/1" class, and PFA analysis reference ranges for Collagen Epinephrine and Collagen ADP assays have been updated. Each update aims to enhance testing accuracy and patient care.